4 active trials 0 recruiting 5 disease areas
| Phase 1 | 2 | |
| Phase 1/2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT01744223 | Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell… | Acute Lymphoblastic Leukemia | Active, Not Recruiting | 2022-07-12 |
| NCT03301168 | Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell… | Acute Lymphoblastic Leukemia | Active, Not Recruiting | 2022-07-12 |
| Phase 1 | ||||
| NCT02477878 | Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After… | Leukemia | Active, Not Recruiting | 2022-07-12 |
| NCT03459170 | Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem… | Hematologic Malignancy | Active, Not Recruiting | 2022-07-12 |
Leukemia (3) · Myelodysplastic Syndromes (MDS) (3) · Acute Lymphoblastic Leukemia (ALL) (2) · Multiple Myeloma (1) · Acute Myeloid Leukemia (AML) (1)